Global STD Diagnostics Market
Medical Equipment

Global STD Diagnostics Market Opportunities And Strategies 2023

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s STD diagnostics market report forecasts the STD diagnostics market size to grow to $12.96 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The STD Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

STD Diagnostics Market Size Forecast
The global STD diagnostics market is expected to grow from $8.38 billion in 2022 to $9.27 billion in 2023 at a compound annual growth rate (CAGR) of 10.61%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The STD diagnostics market is expected to reach $12.96 billion in 2027 at a CAGR of 8.73%.

North America held the largest STD diagnostics market share, and Asia-Pacific was the fastest-growing region in 2022.

Key STD Diagnostics Market Driver ­– Growth In The Prevalence Of STDs
For instance, in 2022, according to the World Health Organization (WHO), an international agency of the United Nations focusing on improving international public health, more than 1 million sexually transmitted infections are acquired every day globally. In addition, there are about 374 million new infections each year, with 1 of 4 STDs, chlamydia, gonorrhea, syphilis, and trichomoniasis. As a result, the rising prevalence of STDs propels the STD diagnostics market.

Request for A Sample Of The Global STD Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Key STD Diagnostics Market Trend – Advancing In STD Diagnostics
Major players are upgrading the testing facilities and techniques to provide a better and fast diagnosis of sexually transmitted diseases. For instance, in May 2022, BD (Becton, Dickinson, and Company), a US-based medical technology company launched a fully automated, high-throughput infectious disease molecular diagnostics platform, known as BD CORTM MX/PX System. This platform unifies and automates the molecular laboratory workflow, from sample processing to diagnostic test results. The first test made accessible on the new platform is the BD CTGCTV2 molecular assay, which is a single test that can identify the three most common non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

STD Diagnostics Market Segment
1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types
2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

STD Diagnostics Market Major Players and Strategies
Major players in the STD diagnostics market are Siemens Healthcare GmbH, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and company, Thermo Fisher Corporation (Affymetrix ), Biocartis NV, Trinity Biotech, Binx Health Inc., Lybrate and NOWDiagnostics Inc.

In December 2021, Quest Diagnostics, a US-based medical laboratory company acquired Labtech Diagnostics for an undisclosed amount. Through this acquisition, Quest Diagnostics broadened its access to diagnostics innovation and provided better diagnostics services to consumers in South Carolina and the southeast. Labtech Diagnostics is a US-based clinical laboratories company providing diagnostics services for STDs and other infectious diseases.

The STD Diagnostics Global Market Report 2023 covers regional data on STD diagnostics market size, STD diagnostics market trends and drivers, opportunities, strategies, and STD diagnostics market competitor analysis. The countries covered in the STD diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

STDs (sexually transmitted diseases) diagnostics refers to analyzing and identifying infectious illnesses spread by sexual contact from an infected person to a healthy person. STD diagnostics are used to detect whether an individual has been infected with sexually transmitted diseases.

View More Reports Related To The STD Diagnostics Market –
In Vitro Diagnostics Global Market Report 2023
Point-Of-Care Diagnostics Devices And Equipment Global Market Report 2023
Diagnostic Enzyme Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn:
https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: